Retinitis Pigmentosa causes sluggish loss of vision. Symptoms start with diminished night vision and later progress to loss of peripheral (side) vision — generating a “tunnel vision” effect. Some individuals might also have trouble identifying colors. The rate of vision change differs in diverse individuals contingent on the hereditary makeup of their disorder. As night vision drops, the aptitude to fine-tune to darkness becomes more challenging. You might stumble over things in the dark, find driving at dusk and night problematic and see poorly in faintly lit rooms, such as a movie theater. While your vision during the day might be totally normal, your incapability to see in dark conditions is considered “night blindness.” In some circumstances, central vision might be affected first, making detail work problematic, such as reading or threading a needle. This might be referred to as macular dystrophy, since the central area of the retina, called the macula, is affected.
Get Stem Cell Therapy for Retinitis Pigmentosa
The area of stem cell therapy for the treatment of retinal degenerative disease holds a lot of hope.
Stem cells including Umbilical Cord Blood-Derived Stem Cells (UCB-SC), Umbilical Cord Mesenchymal Stem Cells (Ucmsc), and Bone Marrow-Derived Mesenchymal Stem Cells (Bm-Msc) have the capacity to restore and improve vision from lost photoreceptors and retinal neurons.
How Stem Cell Therapy for Retinitis Pigmentosa works?
An experimental stem cell-derived treatment designed to preserve and potentially improve vision in people with retinitis pigmentosa (RP) has demonstrated a favourable safety profile in an ongoing Phase I/II clinical trial at the University of California, Irvine. Given that this study is one of the first-ever stem-cell-derived treatments for RP, this safety report is good news and a big step forward. As the experiment continues, we at the Foundation anticipate further conclusions from this study in the coming years.
The procedure entails injecting retinal progenitors, or stem cells in the process of being retinal cells, into the vitreous, a gel-like substance in the middle of the eye. Researchers conclude that the cells will produce proteins that will preserve the patient’s existing photoreceptors stable, avoiding degeneration and maintaining vision. The proteins could also be able to preserve cones that have stopped producing light but have not completely degenerated, according to the researchers.
Cones are photoreceptors that have the power to read, remember faces, and see under bright light.
What Can Retinitis Pigmentosa Patients Expect From Stem Cell Treatment?
The injection of retinal progenitors, or stem cells in the process of being retinal cells, into the vitreous, a gel-like fluid in the centre of the eye, is needed for stem cell therapy for Retinitis Pigmentosa. Researchers believe that the cells will produce proteins that will keep the patient’s existing photoreceptors stable, preventing degeneration and preserving vision. The proteins could also be able to save cones that have stopped producing light but have not completely degenerated, according to the researchers. Cones are photoreceptors charged with extending the ability to read, identify faces, and see in low-light environments. The patient’s vision improves after getting stem cell therapy from Stem Cell Care India.
VIP Treatment to Patients at Stem Cell Care India
- In the VIP recovery room in the advanced facility, the counseling sessions provided to patients at Stem Cell Care India in India occur.
- The effective care staff ensures 24*7 oversight of the patients.
- Global Stem Cell Treatment strongly advises that patients continue in the hospital for a minimum of 3 days.